2011 annual financial data

Galectin Therapeutics 2011 Net margin

Galectin Therapeutics 2011 net margin with verified reported values.

Direct answer

Net margin was Not calculable.

Operating income was -10,409,000 USD and net income was -10,915,000 USD.
Operating cash flow was -5,676,000 USD.

Get free Galectin Therapeutics email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Revenue
0 USD
Operating income
-10,409,000 USD
Net income
-10,915,000 USD
Operating cash flow
-5,676,000 USD